FDA Recall Terminated

FHC Guideline 4000 5.0 GL5 Main Processing Unit - Product Usage: intended to record and stimulate electrophysiological activity, as well as aid in the accurate placement of electrodes and other instruments. Catalogue Number: C0215 UDI: 00873263006740

Recall: Z-2540-2020 · Initiated June 17, 2020

Recall

Recall Number
Z-2540-2020
Event Number
85897
Firm
FHC, Inc.
FEI Number
3002250546
Product Code
GZL
Status
Terminated
Root Cause
Component change control
Initiated
June 17, 2020
Terminated
November 2, 2020
Address
1201 Main St, Bowdoin, ME, 04287-7302

Description

FHC Guideline 4000 5.0 GL5 Main Processing Unit - Product Usage: intended to record and stimulate electrophysiological activity, as well as aid in the accurate placement of electrodes and other instruments. Catalogue Number: C0215 UDI: 00873263006740

Reason

An electrical sub-circuit was not properly connected. Its purpose is to eliminate the possibility of interference with proper performance of the Guideline 5 Main Processing Unit, if an ESD event (greater than 6kV) were to occur.

Action

FHC issued Urgent Medical Device Recall letter dated 6/17/20 via USPS certified return receipt,stating reason for recall, health risk and action to take: FHC, Inc. field representatives will be contacting you to return the effected product and issue a replacement. In the interim, we advise you to stop use of this product. Should you have any further questions regarding this matter you may contact me, by email at [email protected] or by telephone at 207-666-5425.

Distribution

US Nationwide distribution including in the states of CA, NC, TN, TX, WA.

Quantity

6 units